Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice

Journal of Clinical Investigation

Volumn 101, Issue 1, 1998, Pages 51-61

  Sussman, Mark A ^a   Welch, Sara ^a   Cambon, Natalie ^a   Klevitsky, Raisa ^a   Hewett, Timothy E ^a   Price, Robert ^c   Witt, Sandra A ^b   Kimball, Thomas R ^b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b Division of Cardiology   (United States)

^c UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Myocardial diseases; Myocardium; Myofibrils; Ventricular dysfunction

Indexed keywords

ALPHA ACTININ; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; TROPOMODULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; ECHOCARDIOGRAPHY; HEART DILATATION; HISTOPATHOLOGY; MOUSE; MUSCLE FIBRIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIN FILAMENT;

EID: 0031985092     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1167     Document Type: Article

References (37)

1. Manolio, T.A., K.L. Baughman, R. Rodeheffer, T.A. Pearson, J.D. Bristow, V.V. Michels, W.H. Abelmann, and W.R. Harlan. 1992. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am. J. Cardiol. 69:1458-1466.
2. Ho, K.K., J.L. Pinsky, W.B. Kannel, and D. Levy. 1993. The epidemiology of heart failure: the Framingham study. J. Am. Coll. Cardiol. 22(Suppl. A): 6A-13A.
3. Kleber, F.X., and R. Wensel. 1996. Current guidelines for the treatment of congestive heart failure. Drugs. 51:89-98.
4. Garg, R., M. Packer, B. Pitt, and S. Yusuf. 1993. Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J. Am. Coll. Cardiol. 22(Suppl. A):3A-5A.
5. Mann, D.L., Y. Urabe, R.L. Kent, S. Vinciguerra, and G. Cooper IV. 1991. Cellular versus myocardial basis for the contractile dysfunction of the hypertrophied myocardium. Circ. Res. 68:402-415.
6. Schaper, J., T.A. Froede, S. Hein, A. Buck, H. Hashizume, B. Speiser, A. Friedl, and N. Bleese. 1991. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 83:504-514.
7. Beltrami, C.A., N. Finato, M. Rocco, G.A. Feruglio, C. Puricelli, E. Cigola, E.H. Sonnenblick, G. Olivetti, and P. Anversa. 1995. The cellular basis of dilated cardiomyopathy in humans. J. Mol. Cell Cardiol. 27:291-305.
8. Marcus, F.I., G.H. Fontaine, G. Guiraudon, R. Frank, J.L. Laurenceau, C. Malergue, and Y. Grosgogeat. 1982. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 65:384-398.
9. Jindal, N., K.K. Talwar, and P. Chopra. 1994. Ultrastructural and histological study of endomyocardial biopsies from patients of dilated cardiomyopathy: a comparative evaluation and their clinical correlation. Indian Heart J. 46: 329-334.
10. Sussman, M.A., S. Sakhi, P. Barrientos, M. Ito, and L. Kedes. 1994. Tropomodulin in rat cardiac muscle. Localization of protein is independent of messenger RNA distribution during myofibrillar development. Circ. Res. 75:221-232.
11. Gregorio, C.C., and V.M. Fowler. 1995. Mechanisms of thin filament assembly in embryonic chick cardiac myocytes. Tropomodulin requires tropomyosin for assembly. J. Cell Biol. 129:683-695.
12. Fowler, V.M., M.A. Sussman, P.G. Miller, B.E. Flucher, and M.P. Daniels. 1993. Tropomodulin is associated with the free (pointed) ends of the thin filaments in rat skeletal muscle. J. Cell Biol. 120:411-120.
13. Fowler, V.M. 1990. Tropomodulin: a cytoskeletal protein that binds to the end of erythrocyte tropomyosin and inhibits tropomyosin binding to actin. J. Cell Biol. 111:471-482.
14. Weber, A.M., C.R. Pennise, G.G. Babcock, and V.M. Fowler. 1994. Tropomodulin caps the pointed ends of actin filaments. J. Cell Biol. 127:1627-1635.
15. Sussman, M.A., S. Baque, C.-S. Uhm, M.P. Daniels, B. Price, D. Simpson, L. Terracio, and L. Kedes. 1998. Altered expression of tropomodulin in cardiomyocytes disrupts the sarcomeric structure of myofibrils. Circ. Res. In press.
16. Palermo, J., J. Gulick, M. Colbert, J. Fewell, and J. Robbins. 1996. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ. Res. 78:504-509.
17. Gulick, J., A. Subramaniam, J. Neumann, and J. Robbins. 1991. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J. Biol. Chem. 266:9180-9185.
18. Rindt, H., A. Subramaniam, and J. Robbins. 1995. An in vivo analysis of transcriptional elements in the mouse α-myosin heavy chain gene promoter. Transgenic Res. 4:397-405.
19. Ito, M., B. Swanson, M.A. Sussman, L. Kedes, and G. Lyons. 1995. Cloning of tropomodulin cDNA and localization of gene transcripts during mouse embryogenesis. Dev. Biol. 167:317-328.
20. Jones, W.K., I.L. Grupp, T. Doetschmann, G. Grupp, H. Osinska, T.E. Hewett, G. Boivin, J. Gulick, W.A. Ng, and J. Robbins. 1996. Ablation of the murine α-myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J. Clin. Invest. 98:1906-1917.
21. Sussman, M.A., E. Battenberg, F.E. Bloom, and V.M. Fowler. 1990. Identification of two nerve growth factor-induced polypeptides in PC12 cells. J. Mol. Neurosci. 2:163-174.
22. Sussman, M.A., M. Ito, M.P. Daniels, B. Flucher, S. Buranen, and L. Kedes. 1996. Chicken skeletal muscle tropomodulin: novel localization and characterization. Cell Tissue Res. 285:287-296.
23. Cambon, N., and M.A. Sussman. 1997. Isolation and preparation of single mouse cardiomyocytes for fluorescence confocal microscopy. Methods Cell Sci. 19:83-90.
24. Price, R.L., C. Chintanowonges, I. Shiraishi, T.K. Borg, and L. Terracio. 1996. Local and regional variations in myofibrillar patterns in looping rat hearts. Anat. Rec. 245:83-93.
25. Gulick, J., T.E. Hewett, R. Klevitsky, S.H. Buck, R.L. Moss, and J. Robbins. 1997. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ. Res. 80:655-664.
26. Jones, W.K., A. Sanchez, and J. Robbins. 1994. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev. Dynam. 200: 117-128.
27. Maron, B.J., V.J. Ferrans, and W.C. Roberts. 1975. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am. J. Pathol. 79:387-434.
28. Arber, S., J.J. Hunter, J. Ross, M. Hongo, G. Sansig, J. Borg, J.-C. Perriard, K.R. Chien, and P. Caroni. 1997. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 88:393-403.
29. Tsika, R.W., J.J. Bahl, L.A. Leinwand, and E. Morkin. 1990. Thyroid hormone regulates expression of a transfected human α-myosin heavy chain fusion gene in fetal rat heart cells. Proc. Natl. Acad. Sci. USA. 87:379-383.
30. Muthuchamy, M., I.L. Grupp, G. Grupp, B.A. O'Toole, A.B. Kier, G.P. Boivin, J. Neumann, and D.F. Wieczorek. 1995. Molecular and physiological effects of overexpressing striated muscle β-tropomyosin in the adult murine heart. J. Biol. Chem. 270:30593-30603.
31. Patterson, J.H., and K.F. Adams, Jr. 1996. Pathophysiology of heart failure: changing perceptions. Pharmacotherapy. 16:27S-37S.
32. Gallo, P., G. d'Amati, F. Pelliccia, P. Bernucci, C. Cianfrocca, and B. Marino. 1994. Functional significance of myocellular hypertrophy in dilated cardiomyopathy: histomorphometric analysis on 40 endomyocardial biopsies. Am. J. Card. Pathol. 5:11-18.
33. Arai, M., N.R. Alpert, D.H. MacLennan, P. Barton, and M. Periasamy. 1993. Alterations in sarcoplasmic reticulum gene expression in the human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72:463-469.
34. Edwards, J.G., G.E. Lyons, B.K. Micales, A. Malhotra, S. Factor, and L.A. Leinwand. 1996. Cardiomyopathy in transgenic myf5 mice. Circ. Res. 78: 379-387.
35. Lipshultz, S.E., S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, and S.P. Sanders. 1991. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 324:808-815.
36. Vikstrom, K.L., S.M. Factor, and L.A. Leinwand. 1996. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Molec. Med. 2:556-567.
37. Geisterfer-Lowrance, A.A.T., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, and J.G. Seidman. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.